U.S. markets open in 6 hours 18 minutes
  • S&P Futures

    3,814.50
    -24.50 (-0.64%)
     
  • Dow Futures

    31,394.00
    -71.00 (-0.23%)
     
  • Nasdaq Futures

    12,467.00
    -196.75 (-1.55%)
     
  • Russell 2000 Futures

    2,174.50
    -15.20 (-0.69%)
     
  • Crude Oil

    66.89
    +0.80 (+1.21%)
     
  • Gold

    1,695.40
    -3.10 (-0.18%)
     
  • Silver

    25.41
    +0.12 (+0.49%)
     
  • EUR/USD

    1.1893
    -0.0031 (-0.26%)
     
  • 10-Yr Bond

    1.5540
    0.0000 (0.00%)
     
  • Vix

    24.66
    -3.91 (-13.69%)
     
  • GBP/USD

    1.3836
    +0.0008 (+0.06%)
     
  • USD/JPY

    108.4160
    +0.0340 (+0.03%)
     
  • BTC-USD

    49,829.98
    +429.34 (+0.87%)
     
  • CMC Crypto 200

    1,006.72
    +63.55 (+6.74%)
     
  • FTSE 100

    6,630.52
    0.00 (0.00%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Twist Bioscience: Q4 Earnings Insights

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

 

Shares of Twist Bioscience (NASDAQ:TWST) were unchanged after the company reported Q4 results.

Quarterly Results

Earnings per share increased 43.75% year over year to ($0.54), which beat the estimate of ($0.70).

Revenue of $32,432,000 rose by 106.10% year over year, which beat the estimate of $22,670,000.

Guidance

Twist Bioscience hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Nov 23, 2020

View more earnings on TWST

Time: 08:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/jezd66vg

Price Action

Company's 52-week high was at $117.69

Company's 52-week low was at $18.52

Price action over last quarter: Up 87.41%

Company Description

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.